TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Swedish PharmaInsights AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
15,747
|
14,425
|
14,620 |
Financial expenses |
1
|
5
|
0 |
Earnings before taxes |
-453
|
1,644
|
2,753 |
EBITDA |
-552
|
1,648
|
2,753 |
Total assets |
10,871
|
10,468
|
9,022 |
Current assets |
10,871
|
10,468
|
9,022 |
Current liabilities |
3,924
|
3,037
|
3,170 |
Equity capital |
6,947
|
7,431
|
5,852 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
4
|
3
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.9%
|
71.0%
|
64.9% |
Turnover per employee |
3,937
|
4,808
|
7,310 |
Profit as a percentage of turnover |
-2.9%
|
11.4%
|
18.8% |
Return on assets (ROA) |
-4.2%
|
15.8%
|
30.5% |
Current ratio |
277.0%
|
344.7%
|
284.6% |
Return on equity (ROE) |
-6.5%
|
22.1%
|
47.0% |
Change turnover |
1,322
|
-195
|
1,543 |
Change turnover % |
9%
|
-1%
|
12% |
Chg. No. of employees |
1
![]() |
1
|
0 |
Chg. No. of employees % |
33%
|
50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.